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During each heartbeat, cardiac contractility results from calcium-
activated sliding of actin thin filaments toward the centers of myosin
thick filaments to shorten cellular length. Cardiac myosin-binding
protein C (cMyBP-C) is a component of the thick filament that appears
to tune these mechanochemical interactions by its N-terminal do-
mains transiently interacting with actin and/or the myosin S2 domain,
sensitizing thin filaments to calcium and governing maximal sliding
velocity. Both functional mechanisms are potentially further tunable
by phosphorylation of an intrinsically disordered, extensible region of
cMyBP-C’s N terminus, the M-domain. Using atomic force spectros-
copy, electron microscopy, and mutant protein expression, we dem-
onstrate that phosphorylation reduced the M-domain’s extensibility
and shifted the conformation of the N-terminal domain from an ex-
tended structure to a compact configuration. In combination with
motility assay data, these structural effects of M-domain phosphory-
lation suggest a mechanism for diminishing the functional potency of
individual cMyBP-C molecules. Interestingly, we found that calcium
levels necessary to maximally activate the thin filament mitigated
the structural effects of phosphorylation by increasing M-domain ex-
tensibility and shifting the phosphorylated N-terminal fragments back
to the extended state, as if unphosphorylated. Functionally, the ad-
dition of calcium to the motility assays ablated the impact of phos-
phorylation on maximal sliding velocities, fully restoring cMyBP-C’s
inhibitory capacity. We conclude that M-domain phosphorylation
may have its greatest effect on tuning cMyBP-C’s calcium-sensitiza-
tion of thin filaments at the low calcium levels between contractions.
Importantly, calcium levels at the peak of contraction would allow
cMyBP-C to remain a potent contractile modulator, regardless of
cMyBP-C’s phosphorylation state.
muscle activation | muscle regulation | cMyBP-C | structure-function
Cardiac contractility results from the calcium-dependentsliding of actin-based thin filaments toward the centers of
myosin-based thick filaments to shorten the overall length of the
sarcomere, the heart’s elementary contractile unit. Filament sliding
is turned on and off on a beat-to-beat basis by calcium’s binding to,
and release from, the troponin–tropomyosin regulatory complex on
the thin filament. These mechanochemical regulatory processes are
fine-tuned by proteins within the thick filament, including cardiac
myosin-binding protein C (cMyBP-C). Although cMyBP-C is not
essential for cardiac contractility, its importance in contractile
function is evidenced by mutations in the MYBPC3 gene being
a leading cause of inherited hypertrophic cardiomyopathy (1, 2).
Because of the prevalence of this disease (affecting 1 in 500 people)
and the potential for therapeutic intervention, much work during
the last two decades has focused on defining cMyBP-C’s structure
and function within the sarcomere (3).
cMyBP-C has an elongated modular structure comprising 11 Ig
and fibronectin type III (Fn3) domains, numbered C0–C10 from the
N terminus (Fig. 1A) (4, 5). The C-terminal domain (C10) is tightly
bound to the thick filament backbone, and the N-terminal domains
extend radially from the thick filament (6, 7). Thus cMyBP-C’s
N-terminal domains are positioned to bind to neighboring actin
filaments and/or the myosin S2 domain to modulate actomyosin
activity. However, consensus regarding the actual binding sites and
partner(s) in vivo has not yet been reached (8). The N-terminal
domains contain long polypeptide linkers between the C0–C1 and
C1–C2 domains, the latter termed the “M-domain” or “motif”
(Fig. 1A). The M-domain contains four highly conserved serines
(S273, S282, S302, and S307; mouse sequence) in an intrinsically
disordered region of its N-terminal half and a three-helix bundle
(residues 317–351) in its C-terminal region (Fig. 1A) (9, 10).
β-Adrenergic–stimulated phosphorylation of these serines is be-
lieved to enhance cardiac contractility (11, 12), and a high level of
phosphorylation appears to be critical to normal cardiac function,
whereas dephosphorylation has been associated with heart failure
(13–15). Although the mechanistic role of cMyBP-C phosphoryla-
tion in vivo remains unclear, it is known to reduce the extensibility
of the M-domain (10, 16), diminish the binding of cMyBP-C to actin
(17, 18) and to myosin S2 (19), and to tune cMyBP-C’s ability to
modulate actomyosin activity in vitro (20–24).
To gain insight into the function of cMyBP-C in its native
structural environment, we recently developed a total internal
reflectance microscopy (TIRFM)-based assay to visualize the
sliding of actin-based filaments along native cardiac thick (myosin)
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filaments (21, 23). The actin filaments used in this assay are
short 250-nm shards, which allow independent probing of thick
filament areas with and without cMyBP-C (the C- and D-zones,
respectively) (Fig. 1B). Using this assay, we showed that the
sliding velocity of bare F-actin filaments was slowed within the
C-zone of thick filaments and that the degree of slowing was
reduced by phosphorylation of the four serines within the
M-domain (21). Next, we examined the motion of native thin fila-
ments containing the calcium-regulatory troponin–tropomyosin
complex over native thick filaments. We found that cMyBP-C in the
C-zone activated the native thin filaments at low calcium levels (Fig.
1B) and that the level of cMyBP-C–induced activation was lessened
by phosphorylation (23). These findings collectively indicated that
phosphorylated cMyBP-C is a less potent modulator of actomyosin
interactions, as also has been demonstrated in other in vitro model
systems (20, 22).
Here, using in vitro motility assays in combination with atomic
force microscopy (AFM) and electron microscopy (EM), we show
that phosphorylation attenuates cMyBP-C’s function by multimodal
structural ordering within the M-domain, which in turn affects long-
range global interactions between cMyBP-C’s N-terminal domains.
These phosphorylation-dependent structural changes suggest a mo-
lecular basis for cMyBP-C’s ability to modulate cardiac contractility.
In addition, we identify another novel modulatory mechanism by
which calcium limits these intra- and interdomain structural inter-
actions and the ability of cMyBP-C phosphorylation to affect func-
tion. Our findings suggest that phosphorylation and calcium can
antagonistically fine-tune cMyBP-C’s modulation of cardiac con-
tractility, so that phosphorylation plays its greatest role when calcium
levels within the sarcomere are low. The mechanistic phenomena
described here may apply to additional proteins of the contractile
machinery that are tuned by phosphorylation and possibly to other
biological systems regulated through phosphorylation and changes in
intracellular calcium levels.
Results
The Effect of cMyBP-C Phosphorylation on Maximal Thin Filament
Sliding Velocity Is Modulated by Calcium. We applied our TIRFM-
based assay to visualize the sliding of fluorescently labeled, tropo-
nin- and tropomyosin-containing native thin filaments along myosin
thick filaments with high temporal (8.3-ms) and spatial (30-nm)
resolution (Fig. 1B). The maximal sliding velocity of native thin
filaments at high, saturating levels of calcium (0.01 mM free Ca2+,
100 μMATP, 22 °C) was slowed by 56% within the C-zone of thick
filaments containing cMyBP-C with significant levels of endogenous
phosphorylation (∼64% at each site) (21) (Fig. 2A). This slowing
was similar to that previously described for bare actin filaments in
the C-zone of native thick filaments (21). However, in contrast to
our prior studies showing the ability of dephosphorylated cMyBP-C
to inhibit further the sliding velocity of bare actin filaments in the
C-zone (21), the sliding velocity (at high calcium levels) of native
thin filaments over thick filaments containing dephosphorylated
cMyBP-C (∼22% at each site) (21) was equal to that over thick
filaments containing endogenously phosphorylated cMyBP-C (P >
0.05) (Fig. 2A). This unanticipated finding that cMyBP-C phos-
phorylation did not modulate maximal native thin-filament sliding
velocities suggested that either the presence of the troponin and
tropomyosin regulatory proteins on the thin filaments or calcium
itself limits the ability of phosphorylation to modulate cMyBP-C’s
inhibitory function.
To test whether calcium was the cause, we used a conventional
in vitro motility assay, with a surface of randomly oriented myosin
molecules, to examine the inhibitory effect of bacterially expressed
cMyBP-C N-terminal fragments (wild-type C0C3, containing do-
mains C0–C3, and a phosphomimetic mutant, C0C34D) on the
sliding velocity of native thin filaments and bare actin filaments
(lacking regulatory proteins) over a range of calcium concentrations
(Fig. S1 and Fig. 2B). These fragments represent the extremes of
cMyBP-C phosphorylation, the C0C3 fragment being unphos-
phorylated and the mutant C0C34D fragment with aspartic acid
substitutions for the four phosphorylatable serines in the M-domain
representing the fully phosphorylated state. In addition, they have
been shown to recapitulate the modulatory effects of intact cMyBP-C
both in the context of a native thick filament and in the more
simplified in vitro motility assay (21, 24), with the mutant C0C34D
fragment both structurally (16) and functionally (18, 21) identical to
fragments fully phosphorylated by protein kinase A.
Over the upper range of physiological calcium levels (0.5–1.2 μM
free Ca2+, 100 μM ATP, 22 °C), the addition of 1 μM unphos-
phorylated wild-type C0C3 and phosphomimetic C0C34D frag-
ments had similar (P > 0.05) effects on the velocity and fraction of
Fig. 1. Structure and function of cMyBP-C. (A) Schematic diagram of full-length
cMyBP-C. Domains C1 and C2 are connected by the M-domain, containing an
intrinsically disordered N-terminal region with four phosphorylatable serines,
and a more structured C-terminal half. Ig-like domains are shown in blue, and Fn-
like domains are shown in red. (B) Illustration of half of a native thick filamentwith a
native thin filament landing on the tip of the thick filament and being translocated
through the D- and C-zones at the different speeds indicated, as observed in the
TIRFM experiments. (C) Wild-type C0C3 and C1C2 N-terminal fragments used in
motility, AFM, and EM assays. Phosphomimetic counterparts to each fragment were
expressed containing aspartic acid substitutions for the four serines highlighted in A.
Fig. 2. Effects of cMyBP-C phosphorylation and calcium on actin-filament
sliding. (A) Frequency–velocity histograms and Gaussian fits for initial native
thin-filament sliding velocity in the D-zone (blue) and C-zone (red) (compare
with Fig. 1B). Solid symbols and lines indicate motion on wild-type thick
filaments containing highly phosphorylated (∼64%) MyBP-C; open symbols
and dashed lines represent motion on thick filaments containing dephos-
phorylated (∼22%) MyBP-C. Assays were carried out at 100 μMATP and 22 °C
in the presence of 0.01 mM free calcium. (B) Sliding velocities of bare actin
filaments on the surface of randomly oriented myosin molecules (skeletal
muscle proteins) in the presence of unphosphorylated wild-type C0C3 (open
circles, dashed lines) and phosphomimetic C0C34D (closed circles, solid lines),
with (green) and without (black) 0.1 mM free calcium. The assay was carried
out at 1 mM ATP and 30 °C. *P < 0.01 compared with C0C3, Student’s t test.
The impact of cMyBP-C phosphorylation on sliding velocity and its partial
reversal by calcium is similar for actomyosin from cardiac (A and Fig. S1) and
skeletal (B) muscles, suggesting that calcium acts directly on cMyBP-C.
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native thin filaments sliding over myosin (Fig. S1), as anticipated
from the thick filament-based assays containing phosphorylated
cMyBP-C (Fig. 2A). To confirm further that calcium was directly
affecting the function of the phosphorylated cMyBP-C (Fig. 2A) and
phosphomimetic C0C34D fragments (Fig. S1), we repeated the
motility assay with non–calcium-regulated F-actin filaments and
myosin isolated from chicken skeletal muscle (Fig. 2B). In the ab-
sence of calcium, the addition of at least 1 μM of the unphos-
phorylated wild-type C0C3 fragment inhibited actin sliding velocity
(1 mM ATP, 30 °C), and this inhibition was muted in the presence
of phosphomimetic C0C34D (24% vs. 40%, P < 0.01) (Fig. 2B).
Interestingly, calcium eliminated the phosphorylation-dependent
difference (P > 0.05) in the inhibitory capacity between the C0C3
and C0C34D fragments (Fig. 2B) so that the C0C34D was equally
inhibitory. In control experiments lacking fragments, calcium had no
effect (P > 0.05) on the sliding velocities of bare actin filament (Fig.
2B). We conclude that calcium directly limits the ability of phos-
phorylation to modulate cMyBP-C’s inhibitory function rather than
indirectly affecting the actomyosin system. Based on prior structural
(10) and mechanical (16) studies showing that phosphorylation re-
duces the mechanical extensibility of the M-domain, we hypothe-
sized that calcium must ablate the phosphorylation-induced
structural changes, in turn affecting cMyBP-C function.
Calcium Increases the Extensibility of the Phosphorylated M-Domain.
We investigated the effect of calcium on the mechanics of the
M-domain using atomic force spectroscopy. To obtain the cleanest
data (with the smallest number of force-extension peaks), we ex-
amined the extensibility of bacterially expressed wild-type C1C2
(Fig. 1C) and phosphomimetic C1C24D fragments. C1C2 is the
shortest fragment of cMyBP-C that maintains the native connec-
tions between the M-domain and its flanking Ig domains. With only
C1 and C2 serving as attachment handles for pulling on the mole-
cule, the mechanics of the M-domain can be isolated. C1C2 mol-
ecules (Fig. 1C) were adsorbed onto a glass coverslip; then one end
of the molecule was lifted off the surface by retraction of a non-
specifically attached silicon nitride atomic force microscope (AFM)
probe. Force:extension traces of the wild-type C1C2 fragments
showed three distinct peaks (Fig. 3A). The rising phase of the first
peak (LC1) resulted from the initial lengthening of the freely ex-
tensible components within the M-domain and the subsequent drop
from the unfolding of one of the Ig-like domains (16). The next
peak (LC2) resulted from the lengthening of the now unfolded Ig-
like domain and the subsequent drop from the unfolding of the
other stable Ig-like domain. The final peak (LC3) was associated
with full extension of the unfolded molecule before its detachment
from the glass surface or probe (Fig. 3A). The length of LC3
(105.0 ± 8.2 nm; mean ± SD) was consistent with the expected
length (107.8 nm) of a fully linearized peptide chain (308 amino
acids × 0.35 nm per amino acid), suggesting that all secondary and
tertiary structure was removed by pulling with ∼200 pN of force ap-
plied by the atomic force microscope. In comparison, force:extension
traces of the C1C24D fragments showed an additional peak (LC0) and
drop that presumably resulted from the unfolding of a portion of the
M-domain (Fig. 3B) that was partially stabilized by phosphorylation,
as described previously for longer C0C3 fragments (16). Although
phosphomimetic substitution had no effect on the lengths of the
unfolded Ig-like (C1 and C2) domains (ΔLC) (Table S1), it reduced
the final contour length (LC3) of the fully unfolded molecule by 13 nm
(Fig. 3C). This reduction was suggestive of highly stable, phos-
phorylation-dependent structural ordering within the M-domain
that could not be extended by the force applied with the atomic
force microscope.
To determine whether calcium altered the effect of phosphor-
ylation on the development of the highly stable nascent structure
and/or the partial stability of the M-domain, 0.1 mM of free cal-
cium was added to the assay. The presence of calcium had no
significant effect (P > 0.05) on the final contour length or exten-
sibility of the wild-type C1C2 fragments (Fig. 3 C and D). How-
ever, calcium resulted in an 88% reduction in the fraction of
C1C24D fragment force:extension traces that exhibited the unique
initial unfolding peak, indicating that calcium inhibits the phos-
phorylation-induced stabilization of the M-domain (Fig. 3D).
Despite this change in stability, the final contour lengths for the
C1C24D fragments were not significantly different (P > 0.05) in the
presence or absence of calcium and still were shorter (P < 0.05)
than the wild-type C1C2 fragments (Fig. 3C). This result suggests
that phosphorylation has multiple effects on the structure of the
M-domain, with calcium affecting only a subset of these changes
that are detected in the measurement of partial mechanical sta-
bility (Fig. 3D). Could these changes in stability have long-range
effects on cMyBP-C’s structure to affect its function?
Fig. 3. Effects of phosphorylation and calcium on the
structure of the M-domain. (A and B) AFM force:
extension curves for single unphosphorylated wild-
type C1C2 (A) and phosphomimetic C1C24D (B) mole-
cules in the absence of calcium. The initial contour
length of the freely extensible components (LC1) and
final contour length of the fully extended molecules
(LC3) are indicated, as is the change in contour length
associated with the preceding unfolding event (ΔLC).
(C) The final contour lengths of the C1C2 and C1C24D
fragments (LC3 in A and B) in the absence and presence
0.1 mM free calcium. *P < 0.01, LC3 vs. C1C2, Student’s
t test. (D) The relative stability of the M-domain within
the single C1C2 and C1C24D molecules in the absence
and presence of 0.1 mM free calcium as determined
from the number of molecules showing three (freely
extensible M-domain) or four (partially stable M-domain)
peaks in the force:extension curves.
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cMyBP-C Contains a Hinge Point Within the M-Domain. To test the
hypothesis that these local phosphorylation-dependent changes
in the M-domain (Fig. 3) affect the overall structure of cMyBP-C’s
N terminus, we visualized single cMyBP-C molecules in the
absence of calcium using negative staining and rotary shadowing
EM. Baculovirus-expressed full-length cMyBP-C molecules imaged
by negative staining adopted multiple conformations ranging from
elongated flexible molecules with hinge points, similar to chicken
cMyBP-C (25), to amorphous structures (Fig. 4A). The elongated
molecules comprised globular units 3–5 nm in diameter, consistent
with a linear arrangement of individual ∼4-nm Ig and Fn domains
(26). Comparable images of Ig and Fn domains have been obtained
by EM of titin (27) and fibronectin molecules (28).
Although individual Ig and Fn domains were not as readily de-
tected by rotary shadowing EM (Fig. 4B), the images showed cMyBP-
C molecules with similar conformations. These included elongated
bent rods with up to two hinge points (50%, n = 200), shorter, more
rigid straight rods that were potentially folded molecules (31%), and
amorphous structures that could not be classified (19%). Of the
elongated bent-rod structures, 60% contained a single central hinge
creating a V-like conformation, as previously observed for skeletal
MyBP-C (29). The remaining 40% contained a second hinge point
near one end of the molecule that created a third short segment that
has not been previously reported. The segments were 8 ± 2 nm, 15 ±
3 nm, and 20 ± 2 nm in length (Table 1).
To determine whether this second hinge point was within the
M-domain (a possibility suggested by its proximity to one end of the
molecule), we digested the full-length cMyBP-C with calpain. Cal-
pain specifically cleaves between R266 and R270, located near the
first phosphorylation site (S273) (21), releasing a 29-kDa fragment
comprising the C0–C1 domains and the first 17 amino acids of the
M-domain (this fragment has also been referred to as a “40-kDa
fragment” based on its migration on SDS/PAGE) (Fig. S2). After
calpain cleavage (Fig. S2), both elongated bent rods (35 ± 3 nm, n =
100) and short rod-like molecules (9 ± 2 nm, n = 20) were observed
in rotary-shadowed EM images (Fig. 4C). The majority (94%) of
the elongated molecules contained a single hinge point, creating
two segments. The segments on either side of the hinge were
asymmetric and when grouped accordingly had lengths of 15 ± 2 nm
and 20 ± 2 nm, similar to the lengths of the longer segments ob-
served in intact cMyBP-C (Table 1). The shorter (9-nm) rods were
similar in length to the 8-nm segment in intact cMyBP-C (segment 1
in Table 1), suggesting that the hinge point creating this segment is
located near the calpain cleavage site within the M-domain (Fig.
4C). With one hinge point located within the M-domain, we can use
the lengths of each segment (Table 1) and the ∼4-nm size of the Ig
and Fn domains (Fig. 4A) to predict that the central hinge point
occurs near the C5 domain (Fig. 4D). Based on our current reso-
lution (±2 nm), we cannot conclusively determine whether this
hinge occurs between the C4 and C5 domains, within the disordered
∼30-aa cardiac-specific insert in C5 (30), or between the C5 and C6
domains as previously predicted (31). This central hinge point may
be involved with the extension of the molecule from the thick fil-
ament, and the N-terminal hinge may function to alter how the
N-terminal domains interact with actin and/or the myosin S2 region.
cMyBP-C Phosphorylation Promotes Bending of the N Terminus at the
M-Domain. With the presence of a hinge point in the M-domain, it
is possible that the phosphorylation-induced partial stability that we
observed previously with C0C3 (16) and presently with C1C2 in
AFM might promote changes in the structural orientation of the
N-terminal domains. Therefore, we examined the structure of
bacterially expressed wild-type C0C3, PKA-treated C0C3, and
phosphomimetic C0C34D fragments (Fig. 1C) by rotary shadowing
EM (Fig. S3A and Fig. 5 A and B). For each fragment, three dis-
tinct classes of molecules were observed: extended rods, bent rods
with a single hinge point, and compact/closed structures (Fig. 5C).
To quantify the relative distribution of these structures in the wild-
type and phosphomimetic fragments, we measured the distances
between the ends of the molecules in each image (Fig. 5 A–C and
Table 2). Themajority (85%) of the wild-type C0C3molecules showed
the extended (>14 nm between the two ends) or bent (7–14 nm
between ends) conformations (Table 2). The bent rods contained
segments of 8 ± 1 nm and 11 ± 1 nm, the 8-nm segment being
similar to that observed for segment 1 in intact cMyBP-C (Fig. 4D
and Table 1). In contrast, the majority (61%) of the C0C34D
molecules exhibited the compact structure rather than the extended
or bent conformations (Fig. 5B and Table 2). The phosphorylation-
induced closure of the N terminus around this hinge suggests that
local changes in the structure of the M-domain (Fig. 3) promote
global changes in orientation of the N-terminal domains seen in
these rotary shadowed images.
Phosphorylation-Induced Closure of the N-Terminal Domains Is Attenuated
by Calcium. Does calcium’s ability to destabilize the phosphorylated
M-domain (Fig. 3D) mitigate the closure of cMyBP-C’s N-terminal
domains? If so, this effect could account for the loss of phosphory-
lation-dependent modulation of thin filament velocities in the mo-
tility assays in the presence of calcium (Fig. 2). To address this
question, rotary shadowed EM images of the wild-type C0C3, PKA-
treated C0C3, and phosphomimetic C0C34D fragments were
obtained in the presence of 0.1 mM free calcium (Fig. 5D and E and
Fig. S3B). The addition of calcium resulted in fewer of the PKA-
treated and phosphomimetic molecules adopting the compact con-
formation. When quantified, there was an 89% reduction in the
fraction of C0C34D molecules adopting the compact conformation,
with the distribution of molecules in the extended and bent rod
conformations being similar to that in the wild-type C0C3 fragments
regardless of the presence of calcium (Table 2). This calcium-in-
duced reopening of the C0C34D molecules likely results from a dis-
ruption in global interactions within the N-terminal domains (Fig.
3D) and could explain how calcium ablated the ability of phos-
phorylation to modulate the function of cMyBP-C in our motility
assays (Fig. 2).
Fig. 4. Localization of a hinge point within the M-domain. (A) Negatively
stained EM image of full-length baculovirus-expressed cMyBP-C. (Insets) Single
molecules with visible Ig and Fn domains. (B) Rotary-shadowed EM image of
full-length cMyBP-C molecules. (Insets) Examples of bent rods with one and
two hinge points. (C) Rotary-shadowed EM image of full-length cMyBP-C after
treatment with calpain to remove the N-terminal domains. (Insets) Molecules
with only a single hinge, resulting from site-specific truncation of the N-terminal
segment. (D) Schematic diagram of cMyBP-C showing the location of two hinge
points connecting more rigid segments.
Table 1. Lengths of rotary shadowed cMyBP-C and C0C3
segments
Segment 1, nm Segment 2, nm Segment 3, nm
cMyBP-C 8 ± 2 15 ± 3 20 ± 2
cMyBP-C/calpain 15 ± 2 20 ± 2
C0C3 8 ± 1 11 ± 1
Segment numbers refer to labels in Fig. 4D. Lengths are mean ± SD; 50
molecules were measured in each case.
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Discussion
Phosphorylation sites are commonly found in intrinsically disor-
dered regions of proteins, with phosphorylation having both local
effects on the order of secondary structures and global effects on
the orientation of tertiary states (32–34). Such structural rear-
rangements can result in changes in the affinity for binding partners
(33, 35) and/or the mechanics of the phosphoprotein in the bound
state (32, 36). Each of these mechanisms allows exquisite tuning of
the protein interactions involved in complex biological processes.
Here, we determined that phosphorylation of four residues within
an intrinsically disordered region of cMyBP-C’s M-domain signifi-
cantly impacts cMyBP-C’s structure, in turn tuning cMyBP-C’s ability
to modulate actomyosin motility. Phosphorylation-dependent struc-
tural changes within the M-domain were evident by a reduction in
the C1C2 fragment’s final contour length (Fig. 3C) and a change in
mechanical extensibility (Fig. 3D) and were manifest beyond the M-
domain by shifts in the conformation of cMyBP-C’s N terminus (Fig.
5 A and B). The decrease in contour length upon phosphorylation
suggests the formation of secondary and/or tertiary structures within
theM-domain that are so stable that they cannot be unraveled by the
AFM pulling forces (∼200 pN). The formation of these nascent
structures may partially stabilize the M-domain by their surface
charge distribution, allowing more electrostatic interactions with ei-
ther the three-helix bundle or other neighboring domains. In sup-
port of this notion, previous AFM studies showed that the
phosphorylation-dependent mechanical stability of the M-do-
main was sensitive to ionic strength (16). Importantly, these local
alterations within the M-domain appear to have long-range, global
effects on the equilibrium between the extended and compact
conformational states that cMyBP-C’s N terminus adopts (Fig. 5 A
and B). Specifically, phosphorylation shifts the N-terminal domains
(C0C3) from the extended conformation to a compact conforma-
tion as the C0C3 bends in half at a hinge point near the sites of
phosphorylation (Fig. 6). Such conformational closure may directly
control the accessibility of binding sites for both actin and/or myosin
S2, allowing phosphorylation to limit cMyBP-C’s affinity for either
partner, as previously described (17–19), and/or directly alter the
mechanics of cMyBP-C in the structurally bound state (32, 36).
Either scenario could explain the phosphorylation-dependent re-
duction in cMyBP-C’s inhibition of actomyosin motility (Fig. 2).
Interestingly, the presence of calcium at the concentrations found
at the peak of cardiac muscle contraction can effectively reverse the
impact of phosphorylation on the equilibrium of the N-terminal
conformational state (Figs. 5E and 6), the partial stability of the
M-domain (Fig. 3D), and the modulation of actomyosin motility
(Fig. 2 and Fig. S1). Calcium ions are positively charged and thus
may simply shield negative charges within the phosphorylation-
dependent nascent structure that partially stabilizes the M-domain
(Fig. 3D). Alternatively, phosphorylation may result in the formation
of a calcium-binding motif within the M-domain. By either mech-
anism, the presence of calcium could shift the C0C34D fragment’s
conformational equilibrium back to the extended, rod-like con-
formation (Fig. 5E and Table 2) favored by C0C3, thus explaining
why the C0C34D and C0C3 fragments become functionally in-
distinguishable in the motility assay when calcium is present.
The complex intersection of posttranslational modification and
calcium signaling that we report has broad implications for our
understanding of cMyBP-C’s role in modulating cardiac contrac-
tility. The interplay between phosphorylation and calcium on
cMyBP-C structure and function must be dynamic and allow fine
tuning of cMyBP-C’s mechanics within every heartbeat, because
calcium ebbs and flows within each cardiac muscle cell. Although
cMyBP-C’s in vivo binding partner(s) have yet to be defined,
cMyBP-C may serve at least two distinct functional roles: to en-
hance the activation state of thin filaments at low calcium concen-
trations and to limit the maximal activity of actomyosin interactions
once the sarcomere is fully saturated with calcium (23). We recently
have proposed a model based on these roles in which the locali-
zation of cMyBP-C to the sarcomeric C-zone serves to sensitize the
thin filaments to calcium, helping correct an intrinsic inhomogeneity
in calcium activation during the onset of contraction (23). Then, at
the peak of contraction, when calcium levels have increased,
cMyBP-C serves a second role as a governor that effectively throttles
back actomyosin activity. Without the effects of calcium on
cMyBP-C’s structure, phosphorylation of cMyBP-C at normal in
situ levels would partially mitigate both these modulatory roles (21,
23). However, because of the antagonistic interplay between phos-
phorylation and calcium, physiologically saturating levels of calcium
would, in turn, tend to reverse the impact of phosphorylation on
cMyBP-C structure and function so that cMyBP-C remains a potent
modulator of contractility, as demonstrated in vitro (Fig. S2). Thus,
phosphorylation and calcium together fine-tune cMyBP-C’s mod-
ulatory function through changes in cMyBP-C’s structure.
Multiple cardiac proteins, including the myosin regulatory light
chain, troponin I, and phospholamban, appear to be regulated by
phosphorylation-dependent structural transitions similar to those
observed for cMyBP-C (32). It currently is unknown whether the
interplay between phosphorylation and calcium is specific to cMyBP-
C or is a general phenomenon that would impact the structure and
function of these other cardiac contractile proteins by a similar
mechanism. In fact, it is possible that such mechanisms may occur in
Fig. 5. Effects of phosphorylation and calciumon the orientation of theN-terminal
domains. (A and B) Rotary-shadowed EM images of nonphosphorylated wild-type
C0C3 (A) and phosphomimetic C0C34D (B) fragments in the absence of calcium. (C)
Representative EM images (Left) and schematic diagrams (Right) of the extended
rods (Top), bent rods (Middle), and compact/closed structures (Bottom) classified in
each EM image. (D and E) Rotary-shadowed EM images as inA and B for C0C3 (D)
and C0C34D (E) fragments in the presence of calcium. Yellow, blue, and red arrows
point to molecules with extended, bent, and compact structures, respectively.
Table 2. Phosphorylation and calcium affect C0C3 structure
Extended, % Bent, % Compact, %
C0C3 39 46 15
C0C34D 5 34 61
C0C3 + Ca2+ 42 49 9
C0C34D + Ca2+ 37 46 17
One hundred molecules were measured in each case.
Fig. 6. Diagrams of the effects of phosphorylation on the overall structure
of cMyBP-C’s N terminus at low (Top) and high (Bottom) calcium levels.
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other biological systems, because phosphorylation and calcium are
ubiquitous signaling mechanisms critical to protein function.
Materials and Methods
Detailed methods, given in SI Materials and Methods, are summarized here.
Proteins. Native thick and thin filaments and depolymerized myosin were
isolated from FVB mouse hearts (21, 23, 37). cMyBP-C phosphorylation levels
were measured by LC-MS, and, where applicable, thick filaments were
dephosphorylated with λ-phosphatase (New England BioLabs) (21). Skeletal
myosin and F-actin were purified from chicken pectoralis muscle (38, 39).
F-actin and native thin filaments were fluorescently labeled with equimolar
TRITC (37). Wild-type and phosphomimetic mutant (S273, S282, S302, and
S307 to D substitution) C1–C2 (amino acids 151–448) and C0–C3 (amino acids
1–539) mouse cMyBP-C N-terminal fragments were bacterially expressed and
purified (40, 41). Full-length mouse cMyBP-C cDNA was expressed in the
Baculovirus-insect cell system, purified, and where applicable, truncated
with calpain-1 (Calbiochem), as described in SI Materials and Methods.
Motility Assays. The movement of 250-nm shards of thin filaments on thick
filaments was observed (100 μM ATP, 22 °C) by TIRFM (21). The movement of
thin filaments (100 μMATP, 22 °C) and bare actin filaments (1 mMATP, 30 °C) on
randomly oriented surfaces ofmouse cardiac and skeletal muscle myosinmolecules
was observed by epifluorescence microscopy in the absence and presence of
wild-type C0C3 and phosphomimetic C0C34D fragments (18, 21, 42). Free cal-
cium concentrations were determined using MaxChelator software (43).
Atomic Force Spectroscopy. The unfolding of wild-type C1C2 and phospho-
mimetic C1C24D fragments was observed by pulling (180 nm at 700 nm/s)
with an atomic force microscope (MFP-3 Bio; Asylum Research) (16). AFM
force:extension traces were identified by a fingerprinting routine (44) and
then were fit using a wormlike chain model (45).
EM. Full-length and truncated cMyBP-C and wild-type, PKA-treated C0C3, and
phosphomimetic C0C34D fragments were visualized by negative staining
and/or rotary shadowing EM. EM grids were examined using a transmission
electron microscope (FEI), and lengths were measured from digital images
using the line tool in ImageJ.
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SI Materials and Methods
Proteins. Native thick filaments and thin filaments were isolated
from the apex of FVB mouse hearts by mechanochemical means,
as previously described (21, 23, 37). A 10-μL drop of 0.2 U/μL
calpain-1 from porcine erythrocytes (Calbiochem) in 20 mM
imidazole (pH 6.8), 5 μM 2-mercaptoethanol, and 1 mM calcium
acetate was used for the final dissociation of the thick filament to
limit proteolytic cleavage of cMyBP-C as described (21). The
thick filaments were stored in 250 μL of chilled 75 mM NaCl,
5 mMMgCl2, 2 mM EGTA, 1 mMDTT, 7 mM phosphate buffer
(pH 7), 10 mM creatine phosphate, and 2.5 mM ATP. Average
phosphorylation levels in the wild-type thick filaments were
∼64% on serines 273, 282, 302, and 307 within the M-domain,
when measured by LC-MS (21). Where applicable, 50-μL aliquots
of thick filament samples were incubated with 5 μL (2,000 U) of
λ-phosphatase from Escherichia coli (New England BioLabs) and
6.5 μL of 10 mM MnCl2 (1 h, 30 °C) to decrease the phos-
phorylation of the endogenous cMyBP-C to 22% (21). Myosin and
F-actin were purified from chicken pectoralis muscle (38, 39).
Native thin filaments and F-actin filaments were fluorescently la-
beled with equimolar TRITC (21, 37).
Clones encoding domains C1–C2 (amino acids 151–448) and
C0–C3 (amino acids 1–539) of cMyBP-C were inserted into
the bacterial expression vector pET28A using the restriction
sites Nco1 and Xho1. The cDNA was ligated in-frame with the
C-terminal 6His tag, allowing purification of the expressed protein
by passage over Talon His-Tag purification resin (Clontech) (40, 41).
Clones were modified using a Site-Directed QuikChange Mu-
tagenesis Kit (Stratagene), allowing specific amino acids to be
changed to aspartic acid (S273, S282, S302, S307D). For protein
production, clones were transformed into BL21(DE3), grown
and induced with isopropyl β-D-1-thiogalactopyranoside followed
by lysis using HisTALON xTractor Buffer (Clontech). Cell ly-
sates were passed over the resin, aliquots were collected, and
samples were pooled and dialyzed against 1× PBS/10 mM DTT.
Where applicable, the C0C3 fragment was phosphorylated by
incubation with 1 U/μL of PKA (Sigma), and the presence of
phosphate was qualitatively verified by Pro-Q Diamond phos-
phostaining (Invitrogen) as previously described (24).
Full-length cDNA encoding the mouse cMyBP-C protein was
cloned into the pIEx/Bac-3 3C/LIC Expression transfer vector
(Novagen) by ligation-independent cloning using compatible
homologous ends introduced by PCR. Clones were verified by
sequencing followed by recombination into a digested baculovirus
vector. The virus was propagated in Sf9 insect cells, expanded,
and plaque purified. Positive clones were used for further protein
expression. Constructs cloned in-frame into the transfer vector
produced protein with an N-terminal 6His tag, and the C terminus
contained a Strep-tag II, allowing isolation of full-length protein
from affinity columns. Tags were removed from the ends of the
protein using the proteases HRV3C and thrombin.
Truncation of Full-Length cMyBP-C. The calpain-induced truncation
of cMyBP-C was carried out on 20-μL aliquots of 1 mg/mL
cMyBP-C. The aliquots were incubated with 1.2 U (0.45 μL)
calpain-1 (Calbiochem) in 200 μL of 25 mM KCl buffer for
20 min at 30 °C in the presence of 1 mM CaCl2 to ensure pro-
teolytic cleavage. The fragments were diluted in 25 mM KCl
buffer with 1 mM EGTA.
Fluorescence Image Acquisition. Fluorescently labeled actin-based
filament sliding was visualized using a Nikon Eclipse Ti-U
microscope equipped with a Plan Apo oil immersion objective
lens (100×, 1.40 N.A.) for epifluorescence or through-the-objective
TIRFM using a custom Micro Optic Fiber Launch total internal
reflectance microscope (21). A Lumen 200-W metal arc lamp
(Prior Scientific) and 532-nm diode-pumped solid-state, 50-mW
laser (Lasever Inc.) were used for excitation, respectively. An
intensified high-resolution Mega Z 10-bit digital camera running
Piper Control v2.6.09 software (Stanford Photonics) was used for
imaging without pixel binning (93 nm per pixel).
Thick and Thin Filament Assays. The movement of 250-nm shards of
TRITC-labeled thin filaments was observed on thick filaments
from three separate preparations by TIRFM at 22 °C as previously
described (21). Briefly, native thick filaments were incubated on a
Sigmacote (Sigma Aldrich)-coated flow cell in 75 mM KCl, 1 mM
EGTA, 40 mMDTT, 25 mM imidazole, 4 mMMgCl2, adjusted to
pH 7.4 (20 min, 30 °C). The surface was blocked with BSA and
was washed with 1 mM ATP. Next, short, 250-nm sonicated
TRITC-labeled native thin filaments in motility buffer [25 mM
KCl, 1 mM EGTA, 40 mMDTT, 25 mM imidazole, 4 mMMgCl2,
adjusted to pH 7.4, containing an oxygen scavenging system
(0.1 μg/mL glucose oxidase, 0.018 μg/mL catalase, 2.3 μg/mL
glucose)] were incubated on the surface for 1 min. The flow cell
was rinsed three times with motility buffer containing 100 μM
ATP, CaCl2, and short TRITC-labeled native thin filaments. The
CaCl2 concentration was adjusted to achieve 0.01 mM free cal-
cium in solution as determined using MaxChelator software (43)
to account for the 1 mM EGTA in the buffer.
Thin filament motion was recorded at 120 frames/s for 1,000
frames in multiple areas of each flow cell. The image stacks were
opened and inspected for the movement of actin shards. Image
substacks were created for each shard, and the position was tracked
in the x,y visual plane using ImageJ SpotTracker 2D (21). The
fitted positions were converted to nanometers and plotted using
Excel 2013 (Microsoft). The centroid position for each linear track
was used to calculate the displacement from the origin with re-
spect to time and was fitted with a segmental linear regression
using GraphPad Prism 6 for Windows (GraphPad Software) to
calculate velocities, as described (21). The resultant initial and
final velocity distributions, being motion on the tip and within the
C-zone each thick filament, were fitted with a Gaussian using
GraphPad. The statistical significance for velocity comparisons
was determined by the Mann–Whitney–Wilcox test.
Bare Actin Motility Assays. The sliding of bare actin filaments on a
randomly oriented surface of skeletal musclemyosinmolecules was
observed at 30 °C in the absence and presence of wild-type C0C3
and phosphomimetic C0C34D fragments (1 or 2 μM) using an
in vitro motility assay as previously described (18, 21, 42). Briefly,
100 μg/mL of myosin was added to a nitrocellulose-coated flow
cell; then the surface was blocked with BSA. Next, unlabeled actin
filaments were incubated on the surface for 1 min and then were
washed with 1 mM ATP. TRITC-labeled actin filaments were
incubated on the surface for 1 min in motility buffer lacking ATP.
The flow cell was rinsed, and motility buffer containing 1 mM
ATP and 0.5% methyl cellulose was added to the flow cell. CaCl2
was added to the motility buffer to achieve a concentration of
0.1 mM free calcium, and 1 or 2 μM wild-type C0C3 or phos-
phomimetic C0C34D was added where applicable.
For motility, 150 images were collected at 10 frames/s; the
velocity of each moving filament was determined from 25 frames
of each image stack using DiaTrack 3.03 software for Windows
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(Semasopht). The mean velocities ± SEM were determined from
four fields of view for each experimental condition, from four
independent experimental preparations. Data were plotted using
GraphPad Prism 6 for Windows (GraphPad Software), and sta-
tistical significance between velocities was determined using a
Student’s t test.
Thin Filament Motility Assays. The sliding of native cardiac thin
filaments on a randomly oriented surface of cardiac muscle
myosin molecules was observed at 22 °C in the absence and
presence of 1 μM wild-type C0C3 and phosphomimetic C0C34D
fragments using an in vitro motility assay as previously described
(37). The solutions were added to the flow cells as described
above for the bare actin motility assays, but native thin filaments
and 100 μg/mL cardiac muscle myosin were substituted, and the
final ATP concentration was 100 μM. The CaCl2 concentration
was adjusted to achieve free calcium concentrations in solution
as determined using MaxChelator software (43). Data collection
and analysis were identical to those for the bare actin motility
assays, but the movies were down-sampled to two frames/s using
ImageJ software to avoid oversampling. The mean velocities ± SEM
were determined from four fields of view for each experimental
condition from three independent experimental preparations.
Data were plotted using GraphPad Prism 6 for Windows
(GraphPad Software) and fitted with sigmoidal dose–response
curves with variable slopes.
Atomic Force Spectroscopy. The unfolding of wild-type C1C2 and
phosphomimetic C1C24D fragments was observed by AFM as
previously described (16). Briefly, N-terminal fragments were
diluted in 25 mM KCl buffer to an approximate concentration of
10 nM. A 50-μL droplet of the diluted protein was placed on a
precleaned glass slide (Gold Seal) and incubated for 10 min.
Unadsorbed protein was removed by washing three times with
50 μL of dilution buffer. A 150-μL droplet of buffer was left on
the slide over the adsorbed fragments. For experiments exam-
ining the effects of calcium, CaCl2 was added to the 25-mM KCl
buffer to achieve final concentrations of 0.1 mM free calcium.
An MFP-3 Bio atomic force microscope (Asylum Research)
fitted with an uncoated silicon nitride probe (Budget Sensors) was
used to pull on the adsorbed molecules. Before testing, the spring
constant of the probe (average 52 pN/nm) was measured by
equipartition using the Asylum Research software. Force:ex-
tension traces were acquired by scanning square grids (5–20 μm)
with 400–1,600 points. At each point, the probe of the atomic
force microscope was brought into contact with the glass slide
and, after a 1-s dwell, was retracted to 180 nm (farther than
the 3∼100-nm expected length of the unfolded C1C2 fragment)
at 700 nm/s. Probe position and deflection were sampled at
8 kHz during retraction.
AFM traces consisting of three force peaks resulting from
unfolding of the C1 and C2 Ig domains and detachment were
identified using a molecular fingerprinting routine (45) imple-
mented in Matlab (MathWorks, Inc.) after pulling on the C1C2
fragments. Briefly, this technique is carried out by ranking all force:
extension traces collected based on how well they correlate with a
template trace. Based on prior experiments (16), force extension
traces for C1C2 fragments were expected to have either three force
peaks (unfolding of the two IG domains and detachment from the
atomic force microscope probe) or four peaks (including an ad-
ditional peak arising from a stableM-domain). A pair of theoretical
force:extension traces representing these two states (extensible and
nonextensible M-domain) were created and used as templates in
the fingerprinting routine. To assess the relative fractions of
fragments with extensible and nonextensible M-domains accu-
rately, traces from all experimental conditions were compared
against both templates. Force:extension traces identified by the
fingerprinting routine then were fit using a wormlike chain model
(44) of contour lengths, LC0-3, at each force peak. To assess the
effect of calcium on cMyBP-C N-terminal fragment mechanics,
C1C2 and C1C24D were tested in the presence of 0.1 mM free
calcium by the addition of CaCl2 to achieve the desired concen-
tration. Data were plotted using GraphPad Prism 6 for Windows
(GraphPad Software), and statistical significance for LC3 was de-
termined using a Student’s t test.
EM. Full-length and truncated baculovirus-expressed cMyBP-C,
bacterially expressed wild-type C0C3, and phosphomimetic
C0C34D N-terminal fragments were visualized by negative
staining and/or rotary shadowing EM. For negative staining, full-
length protein was diluted to 50 nM in 25 mM KCl buffer. A
5-μL droplet was applied to a carbon-coated grid that had been
freshly (within 30 min) irradiated with UV light using an R-52G
ozone-producing Mineralight lamp (UVP) for 40 min (46), and
the grid was stained with 1% uranyl acetate. For rotary shad-
owing, full-length cMyBP-C and expressed C0C3/C0C34D mol-
ecules were diluted to 0.7 and 0.9 μM in 25 mM KCl buffer.
Proteins then were mixed with an equal volume of glycerol and
sprayed onto freshly cleaved mica. The droplets were allowed to
dry for 40 min; then the mica was placed in a Denton (DV-502)
vacuum evaporator and pumped to <10−7 Torr. Ten micrograms
of platinum wire was evaporated over a 1-min period from a
distance of 9.5 cm at a 6° angle onto the rotating samples, and
then thin carbon was deposited over the platinum replica. The
carbon-supported platinum replica was floated off the mica
onto water and adsorbed onto 400 mesh copper grids. For high-
calcium conditions, CaCl2 was added to the dilution buffer to
achieve 0.1 mM free calcium.
Grids were examined at 80 kV using an FEI Tecnai 12 or Philips
CM120 transmission electron microscope, and digital images were
recorded with an FEI Eagle 4K × 4K CCD camera (Tecnai) or a
TVIPS F224HD 2K × 2K CCD camera (CM120). In all experi-
ments single molecules on each grid were initially classified by eye.
In the rotary-shadowed images, length measurements were made
using the line tool in ImageJ software. The lengths were corrected
for shadow thickness based on the apparent thickness of the
myosin tail, known to be 2 nm in diameter, in control images of
single myosin molecules. All segment length measurements were
reported as mean ± SD.
For intact full-length cMyBP-C, 200 molecules in the images
were determined to be elongated bent rods (with up to two hinge
points), shorter straight rigid rods, or amorphous structures that
could not be classified. The lengths of the segments from the
elongated bent rods were measured. Additional images were
evaluated, and the three segment lengths of 50 molecules with
elongated bent-rod structures containing two hinges were mea-
sured. For calpain-treated cMyBP-C, segment lengths were mea-
sured from the images for 100 elongated molecules (with up to
two hinge points) and 20 short fragments. Additional images were
evaluated, and the two-segment lengths of 50 elongated molecules
with only a single hinge were measured. The two segment lengths
in each molecule were asymmetric and were grouped accordingly
for averaging. For C0C3 and C0C34D molecules in the absence
and presence of calcium, molecular structures were classified as
extended rods, bent rods, and compact/closed by measuring the
distance between the ends of each molecule. A total of 100 mol-
ecules were measured for each condition, with lengths >14 nm
being considered extended rods, lengths between 7 and 14 nm
considered bent rods, and lengths <7 nm considered compacted/
closed conformations. For C0C3 in the absence of calcium, the
segment lengths of 50 molecules having either the extended or
bent conformation were measured.
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Fig. S1. The effects of wild-type C0C3 and phosphomimetic C0C34D N-terminal fragments and calcium on mouse cardiac native thin filaments sliding over a
surface of randomly oriented mouse cardiac myosin molecules. (A) Velocity and (B) fraction moving versus pCa (−log [Ca2+]) plots (100 μM ATP, 22 °C) for native
thin filaments in the absence of cMyBP-C (black symbols and lines) and in the presence of 1 μM wild-type C0C3 (green symbols and lines) and C0C34D (gray
symbols and lines). Data were fitted with sigmoidal dose–response curves with variable slopes. Results show that phosphomimetic substitution allows tuning of
the activating potential of the C0C3 fragment but has no effect on the modulatory mechanism when the thin filaments are fully activated by calcium.
Fig. S2. Calpain cleavage of full-length cMyBP-C. (A) SDS/PAGE shows that at low calpain concentrations cMyBP-C is cleaved into two major fragments with
apparent molecular masses of ∼110 and 40 kDa [confirmed to be 29 kDa by mass spectrometry (1)]. (B) Frequency–length histograms for cMyBP-C segments in
elongated wild-type and calpain-cleaved (25:1 ratio) expressed cMyBP-C molecules. Segment lengths for 60 molecules with two hinges and 40 molecules with
three hinges were measured for the wild-type molecules (black bars). Segment lengths for 94 calpain-treated cMyBP-C molecules with two hinges and six
molecules with three hinges were measured (gray bars). Calpain-treated molecules showed a large reduction in the number with segments ≤8 nm long
(segment 1 in Table 1), and only 6% of the calpain-treated molecules showed a terminal bend (three hinges), as compared with 40% of the undigested
molecules.
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Fig. S3. The effects of phosphorylation and calcium on the orientation of the N-terminal domains. (A and B) Rotary-shadowed EM images of PKA-treated
C0C3 fragments in the absence (A) and presence (B) of 0.1 mM free Ca2+. (C) Blots from a Pro-Q–stained SDS/PAGE gel confirming the presence of phosphate in
the PKA-treated sample. As observed for the phosphomimetic C0C34D fragments (Fig. 5 B and E), PKA treatment resulted in molecules adopting a compact
conformation, and the presence of calcium shifted these molecules into bent or extended conformations.
Table S1. Contour lengths for C1C2 and C1C24D force:extension
curves
Fragment
LC, nm ΔLC, nm
Peak number Peaks
0 1 2 3 0–1 1–2 2–3
C1C2
Mean 45.28 71.91 104.99 26.63 33.07
SD 6.91 7.75 8.16 5.95 5.04
n 24 24 24 24 24
C1C24D
Mean 17.50 37.94 63.66 92.23 20.67 25.73 28.78
SD 5.16 7.73 10.24 9.15 5.73 8.20 5.35
n 21 21 21 19 19 19 16
C1C2 + Ca2+
Mean 44.56 72.47 103.98 28.03 31.51
SD 7.05 9.01 11.55 7.32 7.58
n 13 14 14 13 14
C1C24D + Ca2+
Mean 17.22 38.47 65.28 96.78 19.27 26.81 31.50
SD 1.07 6.80 8.76 12.44 3.21 5.75 8.14
n 2 17 17 17 2 17 17
Shown is the extended contour length (LC) at each numbered peak and
the change in contour length between numbered peaks associated with the
preceding unfolding event (ΔLC). n, number of molecules.
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